SPI1 and myelodysplastic syndrome: In MDS and AML, a subset of mutations at the N terminus of RUNX1 disrupt its interaction with MLL, leading to loss of H3K4me3 marks within PU.1 regulatory regions and decreased PU.1 expression.125 (4) Crosstalk between HMTs and other TCs.